Search Results 301-310 of 17669 for Glucocorticoids
John's Wort, efavirenz, nevirapine, glucocorticoids (other than topical usage), modafinil, pioglitazone, and rifabutin 24. Evidence of cardiac disease ...
the last dose. 7. Chronic, systemically administered glucocorticoids in doses equivalent to >5 mg prednisone daily. Replacement corticosteroids for adrenal ...
If receiving glucocorticoid treatment at screening, treatment must be tapered down and administered with a maximum of 10 mg daily in the last 14 days prior to ...
Ninan J, Nikravangolsefid N, Truong HH, Charkviani M, Prokop LJ, Murugan R, Clermont G, Kashani KB, Domecq Garces JP.
Glucocorticoid therapy within the 14 days prior to randomization that exceeds a cumulative dose of 160 mg of dexamethasone or 1000 mg prednisone. Radiation ...
If induction with glucocorticoidsalone, patient must have failed to attain remission after 3 months and the glucocorticoid dose must be ≥15 mg/day ...
... glucocorticoid treatment such that they would not be able to safely undergone a standardized glucocorticoid taper. Participating Mayo Clinic locations. Study ...
Prior exposure to systemic corticosteroid (glucocorticoid) or immunosuppressive therapy for more than 2 days within the previous 30 days. Current use of ...
- Frequent, repeated use of oral or parenteral glucocorticoids (e.g., prednisone, prednisolone, dexamethasone). Steroid inhalers and topical steroids may be ...
Glucocorticoids for any purpose other than to modulate symptoms from an adverse event of suspected immunologic etiology. Physiologic doses of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!